{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33890267",
  "DateCompleted": {
    "Year": "2021",
    "Month": "07",
    "Day": "05"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "07",
    "Day": "05"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "04",
        "Day": "22"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1055/a-1467-5956"
    ],
    "Journal": {
      "ISSN": "2194-9387",
      "JournalIssue": {
        "Volume": "71",
        "Issue": "6",
        "PubDate": {
          "Year": "2021",
          "Month": "Jul"
        }
      },
      "Title": "Drug research",
      "ISOAbbreviation": "Drug Res (Stuttg)"
    },
    "ArticleTitle": "A Concept for the Reduction of Mucosal SARS-CoV-2 Load using Hypochloric Acid Solutions.",
    "Pagination": {
      "StartPage": "348",
      "EndPage": "350",
      "MedlinePgn": "348-350"
    },
    "Abstract": {
      "AbstractText": [
        "During the next few months or years, vaccination against SARS-CoV-2 infection will significantly reduce the morbidity and mortality of COVID-19. However, additional measures are needed to protect those who are still not immunized. This is even more important in view of new viral mutations that result in increased transmission rates. We propose that the use of long-standing medicinal solutions based on hypochloric acid (HOCl) and intended for application on wounds may be effective as a gargling solution or nasal irrigation in blocking transmission of the virus. Here, we propose the use of HOCl-containing solutions for blocking the transmission of SARS-CoV-2 in combination with other prevention measures. This may constitute another important cornerstone in the fight against the COVID-19 pandemic."
      ],
      "CopyrightInformation": "Thieme. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Otorhinolaryngology, Medical University of Vienna, Vienna, Austria."
          }
        ],
        "LastName": "Mueller",
        "ForeName": "Christian A",
        "Initials": "CA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Team Winter Kompetenztraining, Vienna, Austria."
          }
        ],
        "LastName": "Winter",
        "ForeName": "Michael",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Germany."
          },
          {
            "Identifier": [],
            "Affiliation": "Institute of Clinical Pharmacology, Medical Faculty Carl Gustav Carus, Technische Universit\u00e4t Dresden, Dresden, Germany."
          }
        ],
        "LastName": "Renner",
        "ForeName": "Bertold",
        "Initials": "B"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Drug Res (Stuttg)",
    "NlmUniqueID": "101602406",
    "ISSNLinking": "2194-9379"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents, Local"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Nasal Sprays"
    },
    {
      "RegistryNumber": "712K4CDC10",
      "NameOfSubstance": "Hypochlorous Acid"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Administration, Oral"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Anti-Infective Agents, Local"
    },
    {
      "QualifierName": [
        "epidemiology",
        "prevention & control",
        "transmission",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Hypochlorous Acid"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "Mouth Mucosa"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nasal Lavage"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "Nasal Mucosa"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nasal Sprays"
    },
    {
      "QualifierName": [
        "prevention & control"
      ],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "drug effects",
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Viral Load"
    }
  ],
  "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."
}